Cees Jonker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Cees Jonker has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Miranda G. Dik
Department of Nursing Home Medicine, EMGO Institute, VU University Medical Center, Amsterdam, The Netherlands
3 shared publications A H Kleemans
2 shared publicationsC Van Campen
2 shared publicationsD J H Deeg
2 shared publicationsD L Gerritsen
2 shared publications- Hannie C. Comijs
Department of Psychiatry, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands
2 shared publications
Latest Publications
- 15 August 2009
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 283 (1) , 305
The association between cholesterol metabolism and cognitive decline is moderated by apoe E4
- 15 August 2009
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 283 (1) , 305
The association between cholesterol metabolism and cognitive decline is moderated by apoe E4
- 1 December 2006
- Vol. 37 (6) , 237-42
[Predictors of dementia, the construction of classification trees].
In order to identify persons who are at risk for dementia in an early phase, two classification trees were developed. Data were used from the Longitudinal Aging Study Amsterdam (LASA). The prevalence of dementia in the whole sample was 4.0%. In the first tree age seemed to be the strongest predictor, with an increased risk for persons older than 75. In this group the positive predictive value reached a maximum of 33.3% when the persons had memory complaints and a score on the Mini Mental State Examination (MMSE) <24. In a second classification tree, age was excluded as a predictor because of high association with the other potential predictors. In this tree functional limitations seemed the strongest predictor. In the group of persons with at least one functional limitations, the positive predictive value reached a maximum of 28.8% when the persons had memory complaints and a score <24 on the MMSE. In persons without memory complaints, persons with cardiovascular diseases or diabetes were at increased risk of dementia. Further research is necessary before these classification trees can be implemented in general health care.
- 1 December 2006
- Vol. 37 (6) , 237-42
[Predictors of dementia, the construction of classification trees].
In order to identify persons who are at risk for dementia in an early phase, two classification trees were developed. Data were used from the Longitudinal Aging Study Amsterdam (LASA). The prevalence of dementia in the whole sample was 4.0%. In the first tree age seemed to be the strongest predictor, with an increased risk for persons older than 75. In this group the positive predictive value reached a maximum of 33.3% when the persons had memory complaints and a score on the Mini Mental State Examination (MMSE) <24. In a second classification tree, age was excluded as a predictor because of high association with the other potential predictors. In this tree functional limitations seemed the strongest predictor. In the group of persons with at least one functional limitations, the positive predictive value reached a maximum of 28.8% when the persons had memory complaints and a score <24 on the MMSE. In persons without memory complaints, persons with cardiovascular diseases or diabetes were at increased risk of dementia. Further research is necessary before these classification trees can be implemented in general health care.
- 1 August 2004
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 18 (2) , 159-164
A Model for Quality of Life Measures in Patients with Dementia: Lawton’s Next Step
The introduction of drugs that are claimed to improve cognitive function and activities of daily living in patients with Alzheimer’s disease raises the question of whether these drugs also influence dementia patients’ quality of life (QOL). We describe a hierarchic model of QOL of dementia patients, which can guide the development of measurement instruments. After initially discussing broadly QOL research, we focus on two highly important characteristics of the concept, its broadness and subjectivity, against the background of the relevant literature on QOL in dementia. Dementia-specific dimensions and domains are presented. We identify psychological well-being as the core dimension for QOL of patients with dementia.
- 1 August 2004
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 18 (2) , 159-164
A Model for Quality of Life Measures in Patients with Dementia: Lawton’s Next Step
The introduction of drugs that are claimed to improve cognitive function and activities of daily living in patients with Alzheimer’s disease raises the question of whether these drugs also influence dementia patients’ quality of life (QOL). We describe a hierarchic model of QOL of dementia patients, which can guide the development of measurement instruments. After initially discussing broadly QOL research, we focus on two highly important characteristics of the concept, its broadness and subjectivity, against the background of the relevant literature on QOL in dementia. Dementia-specific dimensions and domains are presented. We identify psychological well-being as the core dimension for QOL of patients with dementia.
- 1 September 2003
- Vol. 76 (1)
The natural history of late-life depression: results from the Amsterdam Study of the Elderly (AMSTEL).
- 1 September 2003
- Vol. 76 (1)
The natural history of late-life depression: results from the Amsterdam Study of the Elderly (AMSTEL).
- 31 August 2003
- Published by Elsevier in Neurobiology of Aging
- Vol. 24 (4) , 583-588
Does aspirin or other NSAIDs reduce the risk of cognitive decline in elderly persons? Results from a population-based study
- 31 August 2003
- Published by Elsevier in Neurobiology of Aging
- Vol. 24 (4) , 583-588
Does aspirin or other NSAIDs reduce the risk of cognitive decline in elderly persons? Results from a population-based study
- 1 August 2003
- Vol. 34 (4) , 146-50
[Apathy syndrome: a clinical entity?].
Apathy is defined as a disorder of motivation that expresses itself at an emotional, cognitive and behavioural level. Apathy can occur as a symptom and a syndrome. In the recent years diagnostic criteria and a number of scales for measuring apathy in elderly with psychiatric or neurological disorders have been introduced. Two scales are specifically developed to measure apathy, the Apathy Evaluation Scale (AES) from Marin and the Apathy Scale (AS) from Starkstein. Both scales have been translated into Dutch. The AS is more convenient. The AS in addition can be used when applying the criteria for the apathy syndrome which has been introduced in 2001 by Starkstein. In addition, the Neuropsychiatric Inventory (NPI) and the 'Gedragsobservatieschaal voor de Intramurale Psychogeniatrie' (GIP) (a scale in Dutch) have an apathy domain. Conceptual problems surrounding apathy have only partly been resolved. The criteria for the apathy syndrome can only be used for assessing the extent of the problem. Apathy and depression are strongly correlated. Studies show that apathy as a syndrome can occur without concomitant depression in the elderly, but regularly occurs besides a depressive disorder, in percentages varying between 9% and 53% of the population under study. Especially the varying validity of an apathy syndrome in relation to late life depression needs further clarification.
- 1 August 2003
- Vol. 34 (4) , 146-50
[Apathy syndrome: a clinical entity?].
Apathy is defined as a disorder of motivation that expresses itself at an emotional, cognitive and behavioural level. Apathy can occur as a symptom and a syndrome. In the recent years diagnostic criteria and a number of scales for measuring apathy in elderly with psychiatric or neurological disorders have been introduced. Two scales are specifically developed to measure apathy, the Apathy Evaluation Scale (AES) from Marin and the Apathy Scale (AS) from Starkstein. Both scales have been translated into Dutch. The AS is more convenient. The AS in addition can be used when applying the criteria for the apathy syndrome which has been introduced in 2001 by Starkstein. In addition, the Neuropsychiatric Inventory (NPI) and the 'Gedragsobservatieschaal voor de Intramurale Psychogeniatrie' (GIP) (a scale in Dutch) have an apathy domain. Conceptual problems surrounding apathy have only partly been resolved. The criteria for the apathy syndrome can only be used for assessing the extent of the problem. Apathy and depression are strongly correlated. Studies show that apathy as a syndrome can occur without concomitant depression in the elderly, but regularly occurs besides a depressive disorder, in percentages varying between 9% and 53% of the population under study. Especially the varying validity of an apathy syndrome in relation to late life depression needs further clarification.
- 1 December 2002
- Published by Springer Nature in Psychopraxis
- Vol. 4 (6) , 180-184
Zeer vroege diagnostiek van dementie: de afgrenzing van normale cognitieve veroudering en depressie
- 1 December 2002
- Published by Springer Nature in Psychopraxis
- Vol. 4 (6) , 180-184
Zeer vroege diagnostiek van dementie: de afgrenzing van normale cognitieve veroudering en depressie
- 1 November 2002
- Vol. 33 (5) , 194-5
[Introduction to the theme. Competence to make decisions in the elderly].
- 1 November 2002
- Vol. 33 (5) , 194-5
[Introduction to the theme. Competence to make decisions in the elderly].
- 1 December 2001
- Vol. 32 (6) , 252-8
[Quality of life and dementia. I. Model of assessment of wellbeing in dementia patients].
The introduction of cholinesterase inhibitors to improve the cognitive function and activities of daily living in patients with Alzheimer disease, raises the question whether these drugs also have the potential to improve the quality of life of these patients. In this article a model is presented to measure quality of life in patients with dementia, in which psychological well-being is chosen as the central measure. The presented model might be the starting point to develop instruments to measure quality of life in dementia. After a short introduction concerning the developments in quality of life research, the two most important characteristics of the concept--multidimensionality and subjectivity--are discussed against the background of the relevant literature on dementia. The dementia-specific dimensions--individual characteristics, psychological, social and physical dimension, and environment--and domains are presented, and put in a hierarchical model.
- 1 December 2001
- Vol. 32 (6) , 252-8
[Quality of life and dementia. I. Model of assessment of wellbeing in dementia patients].
The introduction of cholinesterase inhibitors to improve the cognitive function and activities of daily living in patients with Alzheimer disease, raises the question whether these drugs also have the potential to improve the quality of life of these patients. In this article a model is presented to measure quality of life in patients with dementia, in which psychological well-being is chosen as the central measure. The presented model might be the starting point to develop instruments to measure quality of life in dementia. After a short introduction concerning the developments in quality of life research, the two most important characteristics of the concept--multidimensionality and subjectivity--are discussed against the background of the relevant literature on dementia. The dementia-specific dimensions--individual characteristics, psychological, social and physical dimension, and environment--and domains are presented, and put in a hierarchical model.
- 1 December 2001
- Vol. 32 (6) , 259-64
[Quality of life and dementia. II. Selection of a measurement instrument for wellbeing appropriate for the reference model].
Measuring demented patients' 'quality of life' is an important issue in the Netherlands. Due to diminished cognition and other characteristics of dementia, general instruments are not suitable. A conceptual model for quality of life in dementia should guide instrument choice. We used a recently developed model, in which 'well-being' is indicated as the standard for quality of life. Appropriateness of fit in the model is shown of three important instruments developed in the '90s. Eventually, the 'Dementia Quality of Life instrument' (DQoL or D-QoL) of Brod et al., 1999 was selected as exhibiting the best fit. The DQoL measures well-being as a balance of positive and negative aspects. Other instruments consider, for example, either positive or negative aspects or include determinants of well-being, such as the general health condition. In contrast to the other instruments, the DQoL requires only the patient's own opinion. We plan further validation of the DQoL in Dutch demented patients.
- 1 December 2001
- Vol. 32 (6) , 259-64
[Quality of life and dementia. II. Selection of a measurement instrument for wellbeing appropriate for the reference model].
Measuring demented patients' 'quality of life' is an important issue in the Netherlands. Due to diminished cognition and other characteristics of dementia, general instruments are not suitable. A conceptual model for quality of life in dementia should guide instrument choice. We used a recently developed model, in which 'well-being' is indicated as the standard for quality of life. Appropriateness of fit in the model is shown of three important instruments developed in the '90s. Eventually, the 'Dementia Quality of Life instrument' (DQoL or D-QoL) of Brod et al., 1999 was selected as exhibiting the best fit. The DQoL measures well-being as a balance of positive and negative aspects. Other instruments consider, for example, either positive or negative aspects or include determinants of well-being, such as the general health condition. In contrast to the other instruments, the DQoL requires only the patient's own opinion. We plan further validation of the DQoL in Dutch demented patients.